Abstract

BackgroundPrions, the causative agents of the transmissible spongiform encephalopathies, are notoriously difficult to inactivate. Current decontamination recommendations by the World Health Organization include prolonged exposure to 1 N sodium hydroxide or > 20,000 ppm sodium hypochlorite, or autoclaving. For decontamination of large stainless steel surfaces and equipment as in abattoirs, for example, these methods are harsh or unsuitable. The current study was designed to evaluate the effectiveness of a commercial product containing sodium percarbonate to inactivate prions. Samples of mouse brain infected with a mouse-adapted strain of the scrapie agent (RML) were exposed to a sodium percarbonate-based product (SPC-P). Treated samples were evaluated for abnormal prion protein (PrPSc)-immunoreactivity by western blot analysis, and residual infectivity by mouse bioassay.ResultsExposure to a 21% solution of SPC-P or a solution containing either 2.1% or 21% SPC-P in combination with sodium dodecyl sulfate (SDS) resulted in increased proteinase K sensitivity of PrPSc. Limited reductions in infectivity were observed depending on treatment condition. A marginal effect on infectivity was observed with SPC-P alone, but an approximate 2–3 log10 reduction was observed with the addition of SDS, though exposure to SDS alone resulted in an approximate 2 log10 reduction.ConclusionsThis study demonstrates that exposure of a mouse-adapted scrapie strain to SPC-P does not eliminate infectivity, but does render PrPSc protease sensitive.

Highlights

  • Prions, the causative agents of the transmissible spongiform encephalopathies, are notoriously difficult to inactivate

  • Immunoblotting Residual PrPSc in brain homogenate treated with a low or high concentration of the SPC-containing product (SPC-PL and High concentration SPC-P (SPC-PH), respectively) alone or in combination with 2.5% sodium dodecyl sulfate (SDS) was assayed via Western blot (WB)

  • Immunoreactivity for the di, mono, and unglycosylated forms of PrPSc was present in Low concentration SPC-P (SPC-PL) treated samples after proteinase K (PK) digestion (Figure 1A, lanes 3–5), but was undetectable in SPC-PH treated samples (Figure 1A, lanes 7–9)

Read more

Summary

Introduction

The causative agents of the transmissible spongiform encephalopathies, are notoriously difficult to inactivate. The current study was designed to evaluate the effectiveness of a commercial product containing sodium percarbonate to inactivate prions. Samples of mouse brain infected with a mouse-adapted strain of the scrapie agent (RML) were exposed to a sodium percarbonate-based product (SPC-P). The transmissible spongiform encephalopathies (TSE) include diseases such as scrapie in sheep and goats, bovine spongiform encephalopathy (BSE) in cattle, and Creutzfeldt-Jakob disease (CJD) in humans. Prions are notoriously difficult to inactivate and, in the case of BSE, pose a lethal zoonotic disease risk [2,3]. Effective prion decontamination methods in settings such as abattoirs, for example, are desirable to further minimize the risk of zoonotic TSE transmission. Efficacious decontamination procedures that can be applied to environmental settings are desirable to aid in the control of TSEs such as scrapie and chronic wasting disease, which are horizontally transmitted [5,6]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.